GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambee Pharmaceuticals Plc (DHA:AMBEEPHA) » Definitions » Net Income Including Noncontrolling Interests

Ambee Pharmaceuticals (DHA:AMBEEPHA) Net Income Including Noncontrolling Interests : BDT0.00 Mil (TTM As of . 20)


View and export this data going back to 2004. Start your Free Trial

What is Ambee Pharmaceuticals Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Ambee Pharmaceuticals's Net Income Including Noncontrolling Interests for the six months ended in . 20 was BDT0.00 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Ambee Pharmaceuticals's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambee Pharmaceuticals Net Income Including Noncontrolling Interests Chart

Ambee Pharmaceuticals Annual Data
Trend
Net Income Including Noncontrolling Interests

Ambee Pharmaceuticals Semi-Annual Data
Net Income Including Noncontrolling Interests

Ambee Pharmaceuticals Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Ambee Pharmaceuticals's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Ambee Pharmaceuticals (DHA:AMBEEPHA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambee Pharmaceuticals Plc (DHA:AMBEEPHA) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
BOM:524322 BOM:524661 BOM:524572 BOM:531569 BOM:531210 BOM:526075 BOM:531762 BOM:524400 BOM:530057 BOM:524636 IMNPQ BOM:530207 BOM:523620 BOM:530665 BUD:NUTEX BOM:531173 BOM:530317 BOM:524752 BOM:532989 BOM:506919
Traded in Other Exchanges
N/A
Address
184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Website
https://www.ambeepharma.com
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.

Ambee Pharmaceuticals (DHA:AMBEEPHA) Headlines

No Headlines